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ABSTRACT  
The information obtained from the chemical analysis of specific human excretion 
products (biomarkers) in urban wastewater can be used to estimate the exposure or consumption 
of the population under investigation to a defined substance. A proper biomarker can provide 
relevant information about lifestyle habits, health and wellbeing, but its selection is not an easy 
task as it should fulfil several specific requirements in order to be successfully employed. This 
paper aims to summarize the current knowledge related to the most relevant biomarkers used so 
far. In addition, some potential wastewater biomarkers that could be used for future applications 
were evaluated. For this purpose, representative chemical classes have been chosen and grouped 
in four main categories: (i) those that provide estimates of lifestyle factors and substance use, (ii) 
those used to estimate the exposure to toxicants present in the environment and food, (iii) those 
that have the potential to provide information about public health and illness and (iv) those used 
to estimate the population size. To facilitate the evaluation of the eligibility of a compound as a 
biomarker, information, when available, on stability in urine and wastewater and 
pharmacokinetic data (i.e. metabolism and urinary excretion profile) has been reviewed. Finally, 
several needs and recommendations for future research are proposed.  
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INTRODUCTION 
Relevant epidemiological information about lifestyle habits, public health and wellbeing 
can be obtained from the chemical analysis of urban wastewater. This approach, called 
wastewater-based epidemiology (WBE), is based on the analysis of specific human metabolic 
excretion products (biomarkers) in wastewater as indicators of consumption or exposure of the 
population served by the sewer network under investigation to different substances. WBE has 
been successfully applied as a suitable approach for the estimation of illicit drugs consumption 
(Ort et al., 2014; Thomaidis et al., 2016; Thomas et al., 2012; van Nuijs et al., 2011a; Zuccato et 
al., 2008), but it has also recently been employed to assess other lifestyle-related factors such as 
alcohol (Rodríguez-Álvarez et al., 2015; Ryu et al., 2016), nicotine (Castiglioni et al., 2015b; 
Lopes et al., 2014; Rodríguez-Álvarez et al., 2014b), caffeine (Senta et al., 2015a) and new 
psychoactive substances (NPS) (Kinyua et al., 2015; Reid et al., 2014a; van Nuijs et al., 2014). 
WBE has also been applied to verify community-wide exposure to endocrine disruptors and 
antimicrobial agents in personal care and household products (O’Brien et al., 2015; Rydevik et 
al., 2015). The broad range of information that can be gathered from wastewater opens up the 
possibility of expanding WBE to other human biomarkers providing clues about diet, health, 
diseases and exposure to contaminants. For example by linking exposure to environmental or 
food contaminants with health outcomes such as diabetes or cancer. 
In general, a human biomarker can be an endogenous compound (produced naturally in 
the body) or a metabolite of a xenobiotic/exogenous substance (produced through metabolic 
processes after intentional consumption of a substance, accidental exposure to environmental 
contaminants, as well as through diet or ingestion of a substance). Biomarkers can be classified 
on the basis of their function as biomarkers of exposure (compounds that give information about 
substances consumed or ingested) and biomarkers of effect (indicators of measurable changes or 
alterations in an organism that can be associated with health problems or wellbeing) and on the 
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basis of biological nature (e.g. metabolites, hormones), or of the disease they can indicate (e.g. 
cardiovascular biomarkers, obesity biomarkers) (Pischon, 2009).  
The selection of a specific biomarker is not an easy task, as it needs to satisfy different 
criteria (Figure 1) (Castiglioni and Gracia-Lor, 2015; Gracia-Lor et al., 2016). From a WBE 
perspective, a suitable biomarker must be excreted mainly via urine and concentration levels in 
urine should be at least in the µg/L range to ensure its detection in raw wastewater after dilution 
(Chen et al., 2014).  
 
Excreted via urine 
in consistent amounts 
Detectable in wastewater
Stable in wastewater
Unique source: human metabolism
Requirements of:
• Lifestyle and 
substance use 
biomarkers
• Exposure biomarkers 
from environment 
and food
• Health biomarkers
Low variance in the per capita daily excretion
Daily  per capita excretion not affected by independent 
variables (season, weather or geographic location)
Requirements of:
• Population 
biomarkers
 
Figure 1. Main requirements of a biomarker 
 
A biomarker should also be sufficiently stable in wastewater during the transport (in-
sewer stability) from the input (i.e. toilet) to the sampling point and during sampling, storage and 
analysis (in-sample stability) (McCall et al., 2016a). In wastewater biomarkers can undergo 
further transformation due to microbial activity (Mardal and Meyer, 2014) and/or sorption to 
particulate matter (Baker and Kasprzyk-Hordern, 2011; Daughton, 2012a; McCall et al., 2016a). 
The fate of biomarkers in the sewer can be also predicted by using mathematical models to 
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simulate physicochemical and microbial processes (Bisceglia and Lippa, 2014; McCall et al., 
2016b; Ramin et al., 2016). It is important to note that biomarker transformation pathways in the 
sewer might be different from human metabolic pathways.  
Furthermore, a biomarker should preferably be specific to the compound under 
investigation and unique to human metabolism, thus ensuring that its presence only derives from 
human excretion and not from exogenous sources (Daughton, 2012b). Therefore, 
pharmacokinetic data on human metabolism are necessary but unfortunately this information is 
not always feasible as for many substances it is very limited or do not even exist. This 
information, however, is highly relevant not only to back-calculate the consumption/exposure 
of/to a certain substance by a community, but also to distinguish the amount of a substance 
originating from human metabolism or other sources. Unfortunately, pharmacokinetic studies are 
time-consuming and have to fulfil strict ethical rules. Alternative approaches, which allow for 
the identification and selection of appropriate biomarkers, are therefore required; for example, 
in-vitro studies using liver enzymes, which metabolize the parent compound, help in the 
elucidation of the chemical structure of the metabolites formed (i.e. possible biomarkers) formed 
(Mardal et al., 2016). Computer-based in-silico modelling also allow the prediction of 
pharmacokinetics (Reid et al., 2014a). However these alternatives provide qualitative 
information on metabolism, but not data regarding excretion rates of parent substances and their 
metabolites (Gracia-Lor et al., 2016). 
The present manuscript emerges within the framework of the pan-European inter-
disciplinary network (Sewage analysis CORE group-SCORE), which brings together experts 
from different disciplines interested in standardizing the WBE approach and in coordinating 
international studies (http://score-cost.eu/). The aim of this review is to describe the criteria for 
selecting suitable biomarkers and to give an overview of relevant human (urinary) metabolites 
and potential wastewater biomarkers. Biomarkers have been grouped in four sections: (i) those 
that provide estimates of lifestyle factors and substance use, (ii) those used to estimate the 
8 
 
exposure to toxicants present in the environment and food, (iii) those giving information about 
public health and (iv) those used to estimate the population size. For each group and biomarker, 
a thorough review of the available pharmacokinetic data (i.e. metabolism and excretion profile) 
and stability in urine and wastewater (if known) is provided. This information can be used to 
evaluate their suitability according to the criteria described above. Finally, potential gaps or 
limitations are discussed and future research directions are proposed.  
 
2. LIFESTYLE AND SUBSTANCE USE BIOMARKERS  
Initially, WBE was applied to evaluate lifestyle, in particular illicit drug use within a 
community. Its ability to deliver objective and near-real-time data on drug use, being able to 
detect changes over time and local patterns of use, suggests that this method can be used as a 
complementary and extended data source to existing epidemiological tools. WBE has been well 
established for monitoring the use of cocaine, cannabis, amphetamine, methamphetamine and 
MDMA (3,4-methylenedioxymethamphetamine).  
Additional applications to estimate consumption of other substances, such as alcohol, 
tobacco, caffeine and NPS, have been employed more recently. Alcohol and nicotine (tobacco) 
are probably the most popular and accepted recreational drugs. However, many negative social, 
economic and health aspects have been linked to their use, causing millions of deaths every year 
(World Health Organization, 2015, 2014). It is therefore important and of particular interest for 
policy makers to obtain continuous monitoring data on consumption levels and patterns of use, in 
order to reduce the disease burden related to alcohol and tobacco use. Caffeine use has been 
limitedly investigated, although it is one of the most extensively used legal stimulants, found in 
widely-consumed products, such as coffee, tea, soft and “energy” drinks. Besides monitoring its 
consumption, caffeine has also been proposed as a human biomarker for assessing the size and 
dynamics of the population served (see section 5.3) by a particular wastewater treatment plant 
(WWTP) (Senta et al., 2015a). NPS are emerging narcotic or psychotropic substances which may 
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pose similar threats to public health such as classical illicit drugs (European Union, 2005; 
Papaseit et al., 2014). Due to the delay between their appearance on the market and their addition 
to the list of banned (or controlled) substances, many NPS can be legally purchased, thus 
promoting their proliferation worldwide. Furthermore, new substances appear continuously on 
the market (Bijlsma et al., 2016; EMCDDA, 2015a). WBE has been proposed as a tool for 
providing useful information on temporal and regional trends in the use of NPS.  
Current state and some new features of WBE, with regard to lifestyle and substance use 
are presented in this chapter. Furthermore, specific biomarkers of each lifestyle factor are 
suggested (Table S1) and conceptual approaches for dealing with NPSs using biomarkers in 
wastewater are proposed. 
 
2.1. Illicit drugs 
Among the available epidemiological indicators, general population surveys have been 
traditionally used to assess illicit drug use at the population level. Yet, due to their inherent 
biases, complementary and real-time approaches are needed. The determination of illicit drug 
consumption through wastewater was first theorized by Daughton (Daughton, 2001) and 
implanted by Zuccato et al. using cocaine as an example (Zuccato et al., 2005). Since then, WBE 
has been widened to include other illicit drugs (Asimakopoulos and Kannan, 2016; Castiglioni et 
al., 2008; Hernández et al., 2016; van Nuijs et al., 2011a).  
The biomarkers currently used are either the illicit drug itself (i.e. amphetamine, 
methamphetamine, and 3,4-methylenedioxy-methamphetamine-MDMA) or one of its 
metabolites (i.e. benzoylecgonine (BEG) for cocaine, 11-nor-9-carboxy-delta9-
tetrahydrocannabinol (THC-COOH) for cannabis and morphine or 6-acethylmorphine for 
heroin). 
Cocaine, the first substance studied in WBE, is considered unstable in wastewater; 
however, its unique and stable metabolite (BEG) makes back-calculation to drug consumption 
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more straightforward. It must be noted that significant degradation of BEG from cocaine in 
sewage is also reported (Plósz et al., 2013), which could result in over estimation of cocaine 
consumption if this formation is neglected. Considering human excretion rates, a cocaine: BEG 
ratio around 0.1 or lower can indicate consumption, and any value higher (between 0.1 and 0.7) 
could indicate other sources of cocaine, such as direct disposal (Castiglioni et al., 2011a). 
However, more research is needed in this regard (Bijlsma et al., 2012; Postigo et al., 2010; Van 
Nuijs et al., 2009).  
Δ9-tetrahydrocannabinol (THC), the active ingredient of cannabis, is metabolized to more 
than 20 metabolites after consumption, with 11-nor-∆9-carboxy-THC (THC-COOH) and 11-
hydroxy-THC (THC-OH) being those primarily excreted. THC-COOH has been shown to be 
highly stable and is thus normally used to estimate cannabis consumption, albeit with some 
analytical difficulties arising in multi-residue methods resulting from its non-polarity compared 
to other illicit drugs (Bijlsma et al., 2014; Ort et al., 2014; Pedrouzo et al., 2011).  
Two more recently works studied illicit drugs are ketamine and methadone. Ketamine is a 
dissociative anaesthetic which has been used as a recreational drug, whilst methadone is a 
synthetic opioid used clinically to relieve pain and also as maintenance treatment of opioid 
addicts (Castiglioni et al., 2011b; Preston et al., 2003). Both ketamine and its metabolite 
norketamine are fairly stable in wastewater (Castiglioni et al., 2015a; McCall et al., 2016a), with 
the parent compound generally used as a biomarker for reliable estimation of drug usage. 
Variable stability for methadone has, however, been reported i.e. from high (Senta et al., 2014) 
to low (González-Mariño et al., 2010).  
Opioids use in Europe remains a central issue, reflecting the significant impact these 
drugs still have on mortality and morbidity (EMCDDA, 2015b). In recent years, the production 
of high purity heroin has been rising, thereby increasing heroin-related mortality (UNODC, 
2015). In the human body, heroin is rapidly hydrolyzed to 6-monoacetylmorphine (6-MAM) by 
blood esterases (Bencharit et al., 2003) and further hydrolyzed to morphine in the liver (Smith, 
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2009). In wastewater, heroin shows low stability (González-Mariño et al., 2010). Although 6-
MAM detected in urine is used as a marker of heroin consumption (Staub et al., 2001), 6-MAM 
is not always detected in wastewater as it is not stable in wastewater (Thai et al., 2014). Back-
calculations using 6-MAM as biomarker provides inconsistent results (Been et al., 2015). 
Therefore, morphine is considered as an alternative biomarker for heroin. However, therapeutic 
consumption of morphine should be subtracted from the total measured morphine in sewage 
(Khan and Nicell, 2011; van Nuijs et al., 2011a; Zuccato et al., 2016), which necessitates the 
availability of registered prescribed morphine at the time of wastewater sampling. Morphine is 
also formed in the sewer due to deconjugation of morphine glucuronide and deacetylation of 6-
MAM, which imposes new challenges in back-calculation schemes. Although fractions of 
morphine originating from codeine can be considered negligible (Zuccato et al., 2008), more 
research is needed to find a drug biomarker for heroin which fulfils all the aforementioned 
criteria.  
As shown in Table 1, the most frequently used illicit drug biomarkers are 
benzoylecgonine, amphetamine, methamphetamine, MDMA and THC-COOH (Thomas et al., 
2012). Information about excretion and stability in urine and wastewater of these and other illicit 
drug biomarkers less frequently studied is presented in Table S1.One of the most current 
analytical challenges associated with WBE is represented by chirality. Amphetamine, 
methamphetamine and MDMA are among the illicit drugs that are chiral and as a result they can 
exist as enantiomers (one enantiomeric pair per each chiral centre). The verification of their 
chiral signature in wastewater (i.e. relative proportion of two enantiomers within each 
enantiomeric pair) allows to distinguish between illicit or licit use and direct disposal (Emke et 
al., 2014). It has been shown that the distinction between the consumption or the disposal of 
MDMA could be made by differentiating the loads of the enantiomers present in wastewater. 
Indeed, enantiomeric fractions (EFs) greater than 0.5 indicated illicit use, whilst EFs equal to 0.5 
indicated direct disposal, when EF was calculated as follows:  
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Enantiomeric profiling of MDMA’s metabolites were recently investigated in wastewater 
by Castrignanò et al., suggesting enantioselective metabolism for HMMA (Castrignanò et al., 
2016). Amphetamine and methamphetamine can also be investigated at enantiomeric level, 
however due to both legal and illicit uses, a clear understanding between consumption and direct 
disposal is difficult (Emke et al., 2014; Kasprzyk-Hordern and Baker, 2012).  
 
2.2.  Alcohol 
Following the consumption of alcoholic beverages, the majority of ingested ethanol is 
rapidly metabolized in the human body in a two-stage oxidation process, first to acetaldehyde 
and then to acetic acid. The remaining part is excreted unchanged in urine, sweat and exposed 
breath (Jones, 1990). However, a very small fraction (<0.1%) undergoes a conjugation reaction 
with glucuronic acid to produce ethyl glucuronide (EtG) (Dahl et al., 2002) and with 3'-
phosphoadenosine 5'-phosphosulfate to produce ethyl sulphate (EtS) (Helander and Beck, 2005). 
These metabolites are excreted within a few hours and are detectable in urine for considerably 
longer times (up to 1-2 days, depending on the subject and the alcohol dose) (Helander and 
Beck, 2005; Høiseth et al., 2008), making them unequivocal indicators of recent alcohol 
consumption (Dahl et al., 2011; Dresen et al., 2004).  
EtG was found to degrade ~50% after 18 hours, whereas EtS showed little or no 
degradation (Reid et al., 2011). In addition, no significant differences were found between its 
stability in sewage and in an ethanol-fortified wastewater sample (Reid et al., 2011), indicating 
that it is unlikely to be formed from unconsumed alcohol discarded into the sewer system. 
Taking into account these observations, EtS has been used by several researchers to estimate 
community-wide alcohol consumption through wastewater analysis (Table 1). Typically, its 
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determination in this matrix is performed by direct injection, after filtration and/or 
centrifugation, into a liquid chromatography-mass spectrometry system. The alcohol 
consumption rates estimated through WBE have revealed specific drinking patterns, temporal 
and spatial variations. The study conducted by Reid et al. (Reid et al., 2011), for example, clearly 
showed the weekend elevated drinking pattern in Oslo. Furthermore, the estimated consumption 
rates were in good agreement with sales statistics (Reid et al., 2011). The increase in alcohol 
consumption during the weekend was also found in three Spanish cities, eight Belgian cities an 
done Italian city (Andrés-Costa et al., 2016; Boogaerts et al., 2016; Mastroianni et al., 2014; 
Rodríguez-Álvarez et al., 2015, 2014a; Ryu et al., 2016). However, a different consumption 
pattern was observed during a special event in Valencia, where an increased alcohol use was 
noticeable, reaching the maximum rate on Wednesday, which corresponded to the last day of the 
“Fallas” festivities (Andrés-Costa et al., 2016). Co-consumption of alcohol and cocaine was also 
evaluated through WBE by analyzing cocaethylene, a specific biomarker excreted when the two 
substances are consumed together (Mastroianni et al., 2014; Rodríguez-Álvarez et al., 2015). In 
the studies carried out in Belgium (Boogaerts et al., 2016) and Greece (Gatidou et al., 2016) 
higher alcohol consumption in urbanized cities than in smaller villages was evidenced. Although 
all these studies highlight the potential of EtS as a reliable biomarker for estimating alcohol 
consumption in relative terms, the main limitation is the uncertainty associated with its 
percentage of excretion, which might lead to inaccurate back-calculations in absolute amounts. 
Until now, there have been insufficient pharmacokinetic studies evaluating this percentage to 
provide a unique, representative figure (Halter et al., 2008; Høiseth et al., 2008; Lostia et al., 
2013; Schneider and Glatt, 2004; Wurst et al., 2006). In the aforementioned WBE studies, the 
range 0.010-0.016% (on molar basis) was used by (Andrés-Costa et al., 2016; Reid et al., 2011); 
the median value of the excretion rates provided by Høiseth et al. (Høiseth et al., 2008), 0.011%, 
was used by (Mastroianni et al., 2014; Rodríguez-Álvarez et al., 2014a). Finally, four studies 
(Boogaerts et al., 2016; Gatidou et al., 2016; Rodríguez-Álvarez et al., 2015; Ryu et al., 2016), 
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employed a people-weighted value of 0.012%, based on the data provided by (Høiseth et al., 
2008) and (Wurst et al., 2006).  
 
2.3.  Tobacco  
Nicotine is the principal alkaloid found in tobacco and, although not being directly 
associated with diseases, its addictiveness is the major cause of continued use of tobacco 
products (Hukkanen, 2005). Nicotine is extensively metabolized in humans, with 70-80% of the 
initial dose being converted to cotinine (Benowitz and Jacob, 1994), which is then further 
metabolized into various compounds, the most abundant being trans-3’-hydroxycotinine (Byrd et 
al., 1992). Nicotine and its major metabolites are also excreted as glucuronides. Globally, 
nicotine is excreted unchanged at rates between 8 and 10%, whilst its glucuronide makes up for 
3-5% of the initial dose (Byrd et al., 1992). Cotinine and its glucuronide are excreted at rates 
between 10-15% and 12-17%, respectively, while trans-3’-hydroxycotinine and its glucuronide 
make up for 33-40% and 7-9% of the initial dose, respectively (Hukkanen, 2005).   
Nicotine and its metabolites, cotinine and trans-3’-hydroxycotinine, have been analyzed 
in wastewater as biomarkers (Table S1) to estimate tobacco use in various communities 
(Castiglioni et al., 2015b; Lopes et al., 2014; Mackuľak et al., 2015; Rodríguez-Álvarez et al., 
2014b; Senta et al., 2015a). The three compounds were shown to be stable in wastewater 
samples stored at 4° C and 20° C during 24 h (Chen et al., 2014; Rodríguez-Álvarez et al., 
2014b; Senta et al., 2015a). However, the concentration of the glucuronide of trans-3’-
hydroxycotinine was shown to decrease even in refrigerated samples (i.e., 35% decrease over 8 h 
at 4° C). The authors of the study thus suggested to enzymatically deconjungate the compounds 
prior to extraction and analysis (Rodríguez-Álvarez et al., 2014b).  
The amounts of these compounds in wastewater range from 0.1 to 7 µg/L (Buerge et al., 
2008; Mackuľak et al., 2015; Rodríguez-Álvarez et al., 2014b; Senta et al., 2015a), and the levels 
of cotinine and trans-3’-hydroxycotinine reflected the excretion profiles expected from 
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pharmacokinetic studies, whilst nicotine was found at higher levels (Rodríguez-Álvarez et al., 
2014b; Senta et al., 2015a). The contribution from ashes and cigarettes butts has been advanced 
as a possible explanation for this observation (Castiglioni et al., 2015b; Rodríguez-Álvarez et al., 
2014b; Senta et al., 2015a). In fact, higher nicotine levels have been reported during rain events, 
supporting the hypothesis that ashes and cigarette butts found on streets eventually contribute to 
measured nicotine loads (Senta et al., 2015a). Thus, cotinine and trans-3’-hydroxycotinine were 
used as biomarkers to estimate the amount of nicotine used per capita in a population, as 
indicated in Table 1 (Castiglioni et al., 2015b; Mackuľak et al., 2015; Rodríguez-Álvarez et al., 
2014b; Senta et al., 2015a). 
In some studies, figures were corrected to account for the portion of nicotine absorbed 
during smoking (Castiglioni et al., 2015b; Mackuľak et al., 2015), thus providing estimates of 
the gross amount of number of cigarettes. Additionally, Mackul’ak and co-workers (Mackuľak et 
al., 2015) included a factor to account for losses due to degradation, based on the mean residence 
time of wastewater in sewers. From the estimated nicotine consumption, the number of cigarettes 
smoked per capita was also calculated using as reference value 0.8 mg of nicotine per cigarette 
(Gorrod and Wahren, 1993; Lopes et al., 2014; Rodríguez-Álvarez et al., 2014b) or 1.25 mg of 
nicotine (Castiglioni et al., 2015b). The obtained figures highlighted substantial differences in 
consumption within the same country. For example, researchers from Italy found significant 
differences between the north, centre and south of the country (Castiglioni et al., 2015b; Senta et 
al., 2015a). These results were in agreement with epidemiological data, which suggested a higher 
prevalence of tobacco use in the south (Castiglioni et al., 2015b). Similarly, important 
differences were found in cities in Slovakia and Spain (Mackuľak et al., 2015; Rodríguez-
Álvarez et al., 2014b). In Portugal, estimates of nicotine consumption derived from wastewater 
analysis were in line with findings from a European survey (Lopes et al., 2014).  
Mass loads measured in wastewater were also used to investigate weekly consumption 
patterns and findings suggested that this was stable throughout the week (Chen et al., 2014; 
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Rodríguez-Álvarez et al., 2014b; Senta et al., 2015a). Public holidays and specific touristic 
locations, attracting larger crowds, were the only exceptions (Lopes et al., 2014; Mackuľak et al., 
2015). 
The results obtained show that the measurement of nicotine metabolites is a useful tool 
which could potentially be used to complete current knowledge about the prevalence of tobacco 
use. 
 
2.4. Caffeine 
Caffeine (1,3,7-trimethylxanthine) is the world's most widely consumed stimulating agent 
(Garattini, 1993). It is found in many globally popular products, including tea and cola drinks, as 
well as in some medications and dietary supplements, but the most important source of this 
alkaloid is coffee. 
Caffeine metabolism is extensive (Baselt, 2004), with at least 17 urinary metabolites 
identified in humans (Garattini, 1993). The major metabolites include 1-methyluric acid 
(excretion rate 12-25%), 1-methylxanthine (9-18%), 7-methylxanthine (2-8%), paraxanthine 
(1,7-dimethylxanthine; 4-7%), 1,7-dimethyluric acid (5-8%) and unstable product 5-
acetylamino-6-formylamino-3-methyluracil (4-15%), with a small percentage (1-4%) of the 
initial dose excreted as the parent compound (Carrillo and Benitez, 1994; Garattini, 1993). The 
list of caffeine metabolites identified in humans, together with the excretion rates can be found in 
Table S1. Besides being complex, caffeine metabolism is also rather variable, with the different 
excretion rates observed not only in different studies, but also between individuals within the 
same studies (Carrillo and Benitez, 1994; Grant et al., 1983). These variations can be related 
with genetic differences (Blanchard et al., 1985; Grant et al., 1983) or influenced by other 
factors, such as age (Blanchard et al., 1985; Grant et al., 1983), pregnancy ((Carrillo and Benitez, 
1994; Garattini, 1993) or medications (Callahan et al., 1983). However, certain metabolites, such 
as paraxanthine, 1,7-dimethyluric acid and 1-methylxanthine were found to be less affected by 
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the genetic background compared to the parent compound and they were, therefore, suggested as 
potential biomarkers for caffeine dietary intake (Crews et al., 2001). Furthermore, most of the 
pharmacokinetic data on caffeine metabolism in humans are quite old (Blanchard et al., 1985; 
Grant et al., 1983) and some of them include a relatively low number of subjects (Blanchard et 
al., 1985).  
Due to its wide usage in modern societies, caffeine is among the most ubiquitous 
wastewater micro-contaminants, usually detected at relatively high concentration levels (μg/L) in 
untreated wastewater (Martínez-Bueno et al., 2011; Rosal et al., 2010; Santos et al., 2009). Due 
to this, caffeine was proposed as anthropogenic marker to indicate the discharge of domestic 
wastewater in rivers and lakes (Buerge et al., 2003), but so far has been rarely used as a 
biomarker in a WBE approach. Caffeine has also been proposed as a human biomarker for 
assessing population size and the dynamics of people served by a particular WWTP (Daughton, 
2012b) (see section 5.3).  
However, with the exception of paraxanthine, data on the occurrence of caffeine 
metabolites in wastewater are still very scarce. In fact, the first comprehensive study which 
included most of the major caffeine metabolites (1-methylxanthine, 7-methylxanthine and 
paraxanthine) was published just recently (Senta et al., 2015a). Concentrations of these 
metabolites found in Italian wastewater were similar to those of the parent compound, i.e. in the 
μg/L range. In the same work temporal and spatial patterns of use were also studied and the 
mean mass loads of caffeine and its major metabolites revealed to be slightly lower during the 
weekend, probably due to the lower consumption of coffee. Similar findings for caffeine was 
reported by Rico et al. (Rico et al., 2016; Senta et al., 2015a). On the other hand, no clear 
geographical trends could be observed. Besides being easily detectable, caffeine, 1-
methylxanthine, 7-methylxanthine and paraxanthine fulfill additional important requirement for 
an ideal biomarker - they are stable in wastewater samples stored at 4 °C and 20 °C for 24 h 
(Senta et al., 2015a). However, it is noteworthy that more research is needed in order to select 
18 
 
the most suitable caffeine biomarker in wastewater for the correct interpretation of the obtained 
results within the concept of WBE.  
 
2.5. New Psychoactive Substances  
The detection of NPS and the estimation of their use are especially challenging for drug 
epidemiology, since new compounds appear continuously on the market and consumers do not 
always know the composition of the drugs they take. WBE can shed some light and provide 
additional information, but it is also affected by important challenges. First, pharmacokinetic 
data are essentially non-existent for most NPS, making it extremely difficult to define 
appropriate biomarkers. Second, the prevalence of abuse of a single substance is generally low, 
leading to very low concentrations in wastewater. Finally, their stability in this matrix is largely 
unknown (EMCDDA, 2016; Reid and Thomas, 2016). Based on the limited information 
available, this section attempts to present a selection of potential biomarkers, to be used in WBE 
studies, for the most common classes of NPSs: synthetic cannabinoids, synthetic cathinones, 
phenethylamines, piperazines, tryptamines, arylcycloalkylamines and benzodiazepines 
(EMCDDA, 2015a). The two first groups constitute the largest categories and also account for 
the majority of seizures in Europe (EMCDDA, 2015a).  
Synthetic cannabinoids include a broad range of structurally different compounds sharing 
affinity for the cannabinoid receptors in the brain (Pertwee, 2008). Due to their recent increased 
popularity, their human metabolism is a growing area of research. Several in vitro and in vivo 
experiments have been performed over the past few years and, although individual 
pharmacokinetic profiles remain to be elucidated for many of them, it is generally thought that 
synthetic cannabinoids are extensively oxidized in the human body and excreted as a complex 
mixture of phase I and phase II metabolites (Fantegrossi et al., 2014; Seely et al., 2012). JWH-
type cannabinoids are the most popular drugs within this class. Monohydroxylation, either at the 
N-alkyl side chain, the naphthyl moiety or the indole moiety (followed by the corresponding 
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glucuronidation) has been identified as their major metabolic pathway and, in fact, 
monohydroxylated metabolites have been detected in urine from JWH-type cannabinoids 
consumers (Hutter et al., 2012; Ozturk et al., 2015; Wohlfarth et al., 2013). However, the lack of 
rigorous pharmacokinetic data, essential to calculate excretion rates, prevents from extrapolating 
these analyses to whole communities by the WBE approach. Another important limitation 
concerns their instability in wastewater: the scarce literature available suggests that some 
synthetic cannabinoids and their metabolites are highly labile and tend to get adsorbed to particle 
matter, hindering their determination and sub-estimating the potentially derived abuse 
calculations (Reid et al., 2014a, 2014b). As a reflection of these intrinsic difficulties, to the best 
of our knowledge only the metabolite JWH 018 N-5-hydroxypentyl and the parent compounds 
JWH-210 and JWH-122, have been positively detected in wastewater in two out of all the studies 
dealing with NPS in this matrix (Borova et al., 2015; Reid et al., 2014b) (see Table S1).  
Synthetic cathinones are known to have been abused for approximately 15 years and the 
synthesis of cathinone derivatives has been reported since the late 1920s (Hyde and Adams, 
1928; Prosser and Nelson, 2012). They all refer to cathinone ((S)-2-amino-1-phenyl-1-
propanone), a naturally occurring stimulant found in the leaves of Catha edulis (Khat) (Prosser 
and Nelson, 2012). In general, the drugs are in part extensively metabolized in humans. 
However, some of the synthetic cathinones are also excreted unchanged in urine (Uralets et al., 
2014). Details on the metabolism and detectability of synthetic cathinones can be found in 
original articles and are summarized in several review articles (Ellefsen et al., 2015; Helfer et al., 
2007; Meyer et al., 2014, 2012, 2010a, 2010b; Meyer and Maurer, 2010; Pawlik et al., 2012; 
Pozo et al., 2014; Shima et al., 2014; Staack and Maurer, 2005; Uralets et al., 2014; Welter-
Luedeke and Maurer, 2015). Also, data on the stability, especially under storage conditions, were 
published (Senta et al., 2015b) and highlighted the possible instability of the parent compounds 
under alkaline conditions (Johnson and Botch-Jones, 2013; Tsujikawa et al., 2012). However, 
detailed and comprehensive studies are missing on their chemical stability in wastewater and 
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also biotransformation in the sewer or wastewater should be considered (McCall et al., 2016a). 
Several studies were published on the analysis of synthetic cathinones in wastewater samples, 
with mephedrone, methylenedioxypyrovalerone, methcathinone, methylone and α-
pyrrolidinovalerophenone (α-PVP) being the most frequently detected (Borova et al., 2015; Chen 
et al., 2013; González-Mariño et al., 2016a, 2016b; Kinyua et al., 2015; Mwenesongole et al., 
2013; Ocaña-González et al., 2015; Thai et al., 2016; Tscharke et al., 2016). 
Phenylethylamines are a class of substances related to amphetamine and 
methamphetamine, possessing psychoactive and stimulant effects; however, modification of 
these compounds can lead to potent hallucinogens (Zaitsu et al., 2011; Zawilska and 
Andrzejczak, 2015). They include amphetamine derivatives such as MDMA, 2C and ‘D’ series 
drugs. However, the phenethylamine core is shared among several compounds including 
cathinones and catecholamines. Several metabolism studies have been conducted in an effort to 
understand their metabolic profiles (Ewald et al., 2008, 2006; Lai et al., 2015b; Staack et al., 
2003) but more information is needed.  
Piperazine-like compounds include the original member 1-benzylpiperazine (BZP), its 
methylenedioxy analogue and several phenylpiperazines. They are mainly known to bind to 
serotonin receptors, with BZP additionally producing amphetamine-like stimulant effects (Bye et 
al., 1973; De Boer et al., 2001). A summary with details on the metabolism of piperazines can be 
found in some articles (Maurer et al., 2004; Staack et al., 2001; Staack and Maurer, 2005); 
furthermore, one study showed the detection of metabolites in human urine (Tsutsumi et al., 
2005). Some examples are shown in Table S1. 
Tryptamine is a primary amine alkaloid found widely in nature in both the plant and 
animal kingdoms and known for its hallucinogenic effects (Collins, 2011). Metabolism of some 
synthetic tryptamines has been studied (Kamata et al., 2006; Michely et al., 2015; Narimatsu et 
al., 2008).   
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Arylcycloalkylamines, which include the ketamine derivative methoxetamine (MXE) and 
phencyclidine derivatives, have emerged as legal alternatives to ketamine (Roth et al., 2013). 
MXE, which has gained popularity in several European countries (EMCDDA, 2014), is 
extensively metabolized (Meyer et al., 2013) but it was detected as parent MXE in wastewater 
from Belgium and Switzerland (Kinyua et al., 2015).  
Benzodiazepines are psychoactive substances whose core structure is a benzene ring 
fused to a diazepine ring. Benzodiazepines are known as tranquilizers and are among the most 
commonly prescribed antidepressant medications. Although a useful pharmaceutical, there is 
potential for abuse due to their hypnotic and sedative effects – even to the extent of being used as 
“date rape” drugs (Schwartz et al., 2000). From now on we will refer to those benzodiazepines 
used illegally as design benzodiazepines. Designer benzodiazepines have become a rapidly 
growing class of drugs on the NPS online market, since a medical prescription is not needed. 
Since designer benzodiazepines have increased in popularity, studies have been conducted 
characterizing their human metabolism (Huppertz et al., 2015; Moosmann et al., 2013).  
Up to now, no designer phenethylamines, tryptamines or designer benzodiazepines and 
metabolites have been detected in wastewater and only two studies has reported the stability of 
some phenylethylamines in wastewater (Bade et al., 2016; Senta et al., 2015b).  
Although the interpretation of quantitative results should be done carefully for NPS due 
to the lack of metabolic information, the qualitative monitoring could lead to a better 
understanding of the frequency of use and could identify changes in consumption. 
 
3. EXPOSURE BIOMARKERS FROM ENVIRONMENT AND FOOD  
Two important exposure pathways for potentially harmful compounds are the dietary 
intake and the exposure from the surrounding daily environment. The monitoring of various 
classes of compounds for which exposure commonly occurs through these routes is necessary to 
safeguard public health. Representative chemical classes have been chosen as examples for this 
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paper. Pesticides, mycotoxins and parabens are three classes of compounds for which exposure 
occurs through the intake of contaminated food or absorption through the skin and adverse health 
effects can be foreseen for humans (Błędzka et al., 2014; Heyndrickx et al., 2015; Rizzati et al., 
2016; Warth et al., 2013). Exposure through the indoor environment (furniture, electronics, 
packaging and personal care products (PCPs)) is characteristic for UV-filters, plasticizers and 
brominated flame retardants. 
This section reviews the specific biomarkers of each of the above mentioned chemical 
classes which could be measured in wastewater in order to assess the overall exposure to these 
compounds through a WBE approach. When relevant, we have also included the metabolites of 
these chemicals to be explored as a suitable biomarker. The suggested biomarkers are reported in 
Table S2 including also metabolites, whenever such information is available.  
 
3.1 Pesticides  
Pesticides are chemicals commonly used for control of harmful organisms, such as fungi, 
insects and weeds. They are mostly used for crop protection, but can also be used for livestock 
protection, as well as for other industrial and household purposes, such as termite prevention. 
The general population is exposed to pesticides mainly through diet (Ntzani et al., 2013), but 
also through household use (Trunnelle et al., 2013) and inhalation of polluted air - particularly in 
agricultural areas where aerial spraying of pesticides occurs (Coscollà et al., 2010). Exposure to 
pesticides is of public concern as they may cause health effects such as elevated rates of chronic 
diseases, like cancer or diabetes, as well as neurodegenerative disorders such as Parkinson 
disease, birth defects and reproductive diseases (Rizzati et al., 2016). Young children are the 
most susceptible to be at risk (European Food Safety Authority, 2013). 
There are several types of pesticides and they are generally classified by their chemical 
structure: carbamate, organophosphate or triazine pesticides (Table S2). They may also be 
classified by the type of pest they control, such as herbicides, which are intended to kill weeds 
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and other unwanted plants, and insecticides, which kill insects and other arthropods. Pesticides 
are mostly formulated as mixtures with individual components which may act independently of 
each other, interact or have dose-addition effects (Hernández et al., 2013).  
Until now, there are only two WBE studies (Rousis et al., 2016a, 2016b) published on 
human exposure to pesticides. The first work (Rousis et al., 2016a) proposed for the first time a 
new application for pesticides, where pyrethroid, triazine and organophosphate metabolites were 
monitored in influent wastewater of seven Italian cities. The most frequently detected 
compounds were the specific metabolite of chlorpyrifos and chlorpyrifos-methyl, 3,5,6-trichloro-
2-pyridinol (TCPY), the metabolite of diazinon (2-isopropyl-6-methyl-4-pyrimidinol, IMPY), 
the pyrethroid metabolites 3-phenoxybenzoic acid (3-PBA, common metabolite of about 20 
pyrethroids), 3-(2,2-dichlorovinyl)-2,2-dimethyl-(1-cyclopropane)carboxylic acid (DCCA, 
common metabolite of permetrin, cypermetrin and cyflutrin) and two alkyl phosphate 
metabolites. The second work (Rousis et al., 2016b) applied the novel WBE approach to assess 
further exposure to pyrethroids, concretely 3-PBA, cis-DCCA and trans-DCCA. The obtained 
results were in agreement with the Human Biomonitoring (HBM) profiles in urine samples of the 
general population, reported in the literature.  
Yusa et al. 2015 reviewed analytical methods for HBM of pesticides and found that the 
most commonly biomonitored ones are carbamates, herbicides, neonicotinoids, 
organophosphates, pyrethroids and sulfonylurea herbicides – all of which can be monitored in 
urine samples and they can be good potential biomarkers for WBE. However, some other 
pesticide classes, such as organochlorines, are probably not suited to WBE due to their non-polar 
characteristics and their poor excretion in urine (Yusa et al., 2015).  
As described previously for other substances, the metabolites of pesticides rather than the 
parent substances should be measured in wastewater to avoid contributions from sources other 
than human metabolism. It has to be emphasized that some pesticide metabolites are also formed 
in the environment (i.e. atrazine undergoes dealkylation in water systems forming human 
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metabolites) and therefore more research is needed.  Moreover, there are some common 
metabolites produced by different classes of compounds, such as organophosphate pesticides, 
organophosphate plasticizers and flame retardants, and this should be taken into account in a 
WBE approach. The novel method developed by Rousis et al. is considered as a valuable tool for 
obtaining objective, direct information on pesticide exposure levels and could provide 
complementary information for HBM studies. Table S2 presents the main potential biomarkers 
of exposure to pesticides selected by considering the detection frequency in urine, and the 
concentration levels (Barr, 2008; Yusa et al., 2015).  
 
3.2  Mycotoxins  
Mycotoxins are toxic fungal metabolites that can be found in food and feed which are 
intended for human and animal consumption (i.e. cereals such as rice, maize and wheat). There is 
huge concern of human health risks related to the ingestion of these substances, since they are 
stable in food processing and cooking. Maximum tolerable levels in food commodities were 
therefore legally established in many countries (Comission Regulation 1881/2006, 2006). While, 
nowadays, approximately 400 compounds belong to this group, only 10-15 are considered to be 
priority mycotoxins, due to higher occurrence and toxicity. These latter compounds belong to the 
groups of aflatoxins, ochratoxins, patulin and fusarium toxins (tricothecenes, fumonisins, 
zearalenone and zearalenone derivatives) (Anfossi et al., 2016; Turner et al., 2015). HBM studies 
performed on general population have shown that the most studied mycotoxin biomarkers in 
urine samples are aflatoxin M1 (AFM1), ochratoxin A (OTA), deoxynivalenol (DON), nivalenol 
(NIV), fumonisin B1 (FB1) and zearalenone (ZON) (H Fromme et al., 2016; Heyndrickx et al., 
2015). If mycotoxin contaminations are going to be increased in the near future due to higher 
global food demand and global climate and environment changes, new methods are needed to 
evaluate the human exposure to mycotoxins (Marroquín-Cardona et al., 2014). Thus, a novel 
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approach such as the WBE can be useful to provide complementary information to existing 
methods.  
Few studies dealing with the determination of mycotoxins in wastewater have been 
published. The studied analytes were detected at very low concentrations (few ng/L), but at high 
detection frequency. In addition to parent compounds, some human metabolites were also 
investigated. The detected mycotoxins were DON, beauvericin (BEA), 3-Acetyldeoxynivalenol 
(3-AcDON), NIV, ZON, α-zearalenol (α-ZOL) and β-zearalenol (β-ZOL) (Kolpin et al., 2014; 
Laganà et al., 2004; Schenzel et al., 2012, 2010; Wettstein and Bucheli, 2010). None of these 
studies attempted to apply the WBE approach to these substances; they had only a monitoring 
scope. In the present paper a selection of mycotoxins and their related potential biomarkers for a 
WBE approach were reported for the first time (Table S2). 
 
3.3  Parabens  
Parabens are a group of chemicals that is drawing a lot of interest in the current 
discussion given their potential endocrine disrupting properties, since studies have shown that 
they have potential adverse health effects (Hu et al., 2013; Kim et al., 2015; Zhang et al., 2013). 
This has raised concern considering their widespread use. Parabens are used as preservatives in 
many different products, such as cosmetics, PCPs and foods, and can be commonly found in 
household products.  
Some studies also investigated the occurrence and fate of parabens in wastewater 
(González-Mariño et al., 2009; Gracia-Lor et al., 2012a; Kasprzyk-Hordern et al., 2008), but not 
from a WBE perspective. Therefore, a list of known urinary biomarkers for paraben exposure is 
reported in Table S2. Future research should be addressed in order to explore paraben 
biomarkers for WBE.  
 
3.4.  UV-Filters  
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Overexposure to ultraviolet (UV) radiation has been associated with skin disorders, such 
as cancer (Ramos et al., 2016). This led to the widespread usage of UV filters in a variety of 
personal care products to protect against UV radiation, i.e., sunscreen, cosmetics, beauty creams, 
body lotions, hair sprays and shampoos (Brausch and Rand, 2011). UV filters are also used in 
food packages, plastics and textiles to prevent polymer degradation. Hence, human exposure 
occurs through multiple routes such as dermal absorption, ingestion of contaminated food and 
tap water (Valle-Sistac et al., 2016). Two major types of UV filters are currently available; 
organic UV filters are used to absorb UVA and/or UVB radiation, whereas inorganic UV filters 
mainly reflect the radiation. Given the high photostability and lipophilicity, many UV filters can 
enter biological membranes and bioaccumulate in the body, including in the placental tissues 
(Valle-Sistac et al., 2016).  However, it is important to note that most UV-Filters are released 
into the sewers without going through the body (Daughton and Ruhoy, 2009; Ruhoy and 
Daughton, 2008). This fact would contribute to a large uncertainty in its estimation. 
Urinary analysis has frequently detected UV filters at various levels, demonstrating 
human exposure (Dewalque et al., 2014; Louis et al., 2015). Despite their widespread use, 
between 2010 and 2015 only 20 studies have been published in peer reviewed journals dealing 
with UV filters detection in wastewater (Ramos et al., 2016). Yet, available data indicates that 
major UV filters groups, i.e. benzophenone derivatives, p-aminobenzoic acid derivatives, 
camphor derivatives, benzotriazole derivatives, salicylate derivatives, benzimidazole derivatives, 
triazine derivatives, cinnamate derivatives, crylene derivatives, and dibenzoyl methane 
derivatives, are ubiquitous in wastewater with concentrations ranging from the ng/L to the mg/L 
level (Gago-Ferrero et al., 2011; Rodil et al., 2012). Evidence from mammalian studies indicate 
that various UV filters are endocrine disruptors, acting as estrogenic, antiestrogenic, 
antiandrogenic or antithyroid (Louis et al., 2014). These results find support in recent 
epidemiologic studies reporting an association between human urinary levels of certain UV 
filters and couples fecundity, i.e. BP-2 (Louis et al., 2014), and decrease semen quality, i.e. BP-3 
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and BP-8. Therefore, (Louis et al., 2015) highlighted the importance of further studies exploring 
human exposure to UV filters. Despite the presence of UV filters has been reported in 
wastewater (Ramos et al., 2016; Tsui et al., 2014) no WBE approaches have been yet tested to 
evaluate human exposure to these substances. However, the high stability of these compounds 
and the indication of particular metabolite signatures (Le Fol et al., 2015) suggest potential 
biomarkers for UV filters in wastewater based biomarkers to support epidemiological studies 
(Table 1 and S2). 
 
3.5.  Plasticizers 
  Plastics are very versatile materials typically consisting of organic polymers of high molecular 
mass, which may contain other substances. Manufacturers often add different chemicals to 
plastics to give them specific characteristics, such as flexibility, resilience and pliability. These 
plasticizers mainly include phthalates and adipates, and because of their environmental 
persistence and their widespread use, it is unsurprising that they can be found in wastewater and 
in the receiving environment (Barnabé et al., 2008; Gao and Wen, 2016; Olofsson et al., 2013; 
Zolfaghari et al., 2014). Some of these chemicals and/or their derivatives interfere with 
endogenous hormone signalization in animals and humans, raising concerns about their potential 
to cause long-term diseases (Joint Fao Oms Expert Committee On Food Additives, 2010). In 
particular phthalates (e.g. bis(2-ethylhexyl) phthalate and, dibutyl phthalate) were associated 
with the disruption of hormonally-mediated pathways, as well as increased risk for cancer 
(“Toxicological profile for di(2-ethylhexyl)phthalate (DEHP),” 2002, “Toxicological profile for 
Di-n-butyl-Phthalate,” 2001). Furthermore, epidemiological observational studies suggest that 
there is a consistent association of blood and urine concentrations of phthalates, and some 
effects, such as those mentioned above (Joint Fao Oms Expert Committee On Food Additives, 
2010; Kim et al., 2015; Wang et al., 2016). Due to a better toxicological profile (Bhat et al., 
2014) and a better blood compatibility (Zhong et al., 2013), other plasticizers, such as di-
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isononyl cyclohexane-1,2-dicarboxylate (DINCH), have been increasingly used in recent years 
as alternatives in PVC films and medical devices. Metabolites of phthalates, adipates, and 
DINCH have been found in urine (Fromme et al., 2016; Guo et al., 2011; Herrero et al., 2015; 
Loftus et al., 1993; Silva et al., 2007), but their presence in wastewater has never been 
investigated. For a list of known biomarkers in urine see Table S2. 
 
3.6  Flame retardants  
Flame retardants (FRs) are chemical additives for manufactured materials, such as 
plastics and textiles, to inhibit, suppress, or delay the production of flames to prevent the spread 
of fire. Brominated flame retardants (BFRs) and organophosphorus flame retardants (PFRs) are 
the most used classes of organic FRs. Due to their high log Kow, BFRs are lipophilic and 
preferentially retained in the human body, e.g. in the blood or adipose tissue. They are only 
slowly metabolized to hydroxylated metabolites (e.g. HO-PBDEs), which are also retained in the 
body and thus not excreted in the urine. The presence of BFRs in the sewer system is largely due 
to direct input from the indoor environment, following washing out of dust and being associated 
with particles. PFRs are less persistent and rapidly metabolized in the human body (Van den 
Eede et al., 2013), they have been measured in municipal wastewater in Europe (Loos et al., 
2012; Marklund et al., 2005), Australia (O’Brien et al., 2014) and United States (Schreder and 
La Guardia, 2014). PFRs metabolites are excreted via urine and they are thus suitable biomarkers 
to assess human exposure to PFRs (Van den Eede et al., 2015); however, there are no reports on 
the presence of PFR metabolites in wastewater and no studies testing them in a WBE approach 
(Table S2).  
 
4. HEALTH BIOMARKERS  
Community health programs play an essential role for public health agencies to monitor 
and evaluate the present status of health in a community and measure the success of programs 
29 
 
aimed at improving it. Current challenges mainly consist of the quick and reliable evaluation of 
the overall health of a population, and detect possible health and illness threats such as 
pandemics or higher prevalence of diabetes or cancer. 
The quantitative measurement of specific exogenous and endogenous biomarkers related 
to these diseases in wastewater has the potential to provide rapid information on different factors 
related to public health and illness. Specific classes of pharmaceuticals such as antibiotics and 
benzodiazepines and their metabolites are exogenous compounds, which can be related to their 
use for specific illnesses or diseases, whereas endogenous compounds, such as α-fetoprotein, 
chroriogonadotropin (hCG) and isoprostanes, are more directly related to cancer or stress. 
In this section, both exogeneous and endogenous specific biomarkers are presented and 
suggested to monitor health issues (Table S3) through the WBE approach. In addition, DNA-
based approaches, currently applied in the field of WBE, have been reviewed. 
 
4.1 Pharmaceuticals  
 4.1.1  Antibiotics  
Antibiotics (ABs) can be suitable biomarkers for representing human health status 
associated with bacterial infections. The determination of reliable data on their consumption is of 
interest as AB use is one of the main factors responsible for AB resistance (Euro-CDC, 2012). 
WBE may give a better understanding of real time use and misuse of ABs at the population 
level, by supporting for example prescription data from official sources and annual sales.  
Many ABs are excreted unchanged in urine (Castiglioni et al., 2006; Huang et al., 2011), 
hence, parent drugs are generally targeted as biomarkers (Table S3). However, the selection of a 
significant AB biomarker should not be limited to the parent drug only; in fact, the investigation 
of specific metabolites is adding specificity to the analysis avoiding biases coming from the 
direct disposal of the AB. This is particularly relevant for ABs widely used for veterinary 
treatments. The most targeted classes of ABs are β-lactams, quinolones and fluoroquinolones, 
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sulphonamides, tetracyclines and macrolides. Apart from β-lactams that undergo easy hydrolysis, 
sulphonamides and macrolides are very persistent, and are therefore also detected in treated 
wastewater (Jelic et al., 2012). Stability of the ABs metabolites in wastewater is less understood. 
The occurrence of ABs in influent wastewater has been widely investigated in several 
countries (Gracia-Lor et al., 2012b; Kümmerer, 2009; Verlicchi et al., 2012). Seasonal variability 
of population-normalized mass loads was observed by Castiglioni et al. 2006, using the WBE 
approach, showing a difference in percentage from winter to summer of 47, 77 and 100 for 
ciprofloxacin, ofloxacin and sulphamethoxazole, respectively (Castiglioni et al., 2006). 
Temporal monitoring of ABs at several time scales showed a higher variability monthly/hourly 
than daily/weekly along with seasonality in mass fluxes for ciprofloxacin, ofloxacin and 
clindamycin (Coutu et al., 2013). Deconjugation during in-sewer transport may influence the 
influent loading of sulfamethoxazole (Snip et al., 2016) depending on the type and size of the 
served catchment (Polesel et al., 2016). Application of WBE helped in determining the usage of 
ABs in areas where consumption data were scarce or a proper regulation was missing, revealing 
an excessive use in China (Yuan et al., 2015).  
 
4.1.2 Benzodiazepines  
Benzodiazepines are used therapeutically for a considerable number of applications, 
including anxiety and sleep disorders. Their primary mode of action is an enhancement of the 
action of the neurotransmitter gamma-aminobutyric acid which may result in anticonvulsant, 
anxiolytic, hypnotic, muscle relaxant and sedative effects. Benzodiazepines and benzodiazepine 
analogs are commonly prescribed; however, they are also among the most frequently abused 
prescription medications (Button, 2015). Despite the risk for abuse, approximately 5.2% of US 
adults between 18 and 80 years of age used benzodiazepines in 2008, with a double prevalence 
for women than men (Olfson et al., 2015). As such, monitoring of benzodiazepines is of public 
concern.  
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Monitoring benzodiazepines in populations could be achievable via WBE as they are 
normally halogenated and hence resistant to biodegradation (Kosjek et al., 2012). Multiple 
studies have already identified both parent benzodiazepines and their urinary metabolites in 
wastewater influent (Baker et al., 2014; Borova et al., 2014; Castrignanò et al., 2016; Fernández 
et al., 2014; Hummel et al., 2006; Kosjek et al., 2012; Racamonde et al., 2015, 2014). 
Differences in the behavior of benzodiazepines are associated with differences in functional 
substituent groups, and mainly the hydroxylated tranquilizers, oxazepam, and temazepam, were 
reported to be present in influent and effluent wastewater (Bijlsma et al., 2012; Hummel et al., 
2006; Löffler et al., 2005). 
A summary of the most commonly prescribed and detected benzodiazepine parent 
compounds and their metabolites, which have been identified in urine, in addition to 
identification in wastewater and stability data, when available, are presented in Table S3.  
 
4.1.3 Other pharmaceuticals  
Even if many works have analysed the presence of pharmaceuticals in urban wastewater, 
only a few studies investigated these chemicals as WBE biomarkers. Some examples can be found 
in Table 1. Furthermore, a list of proposed pharmaceuticals is given in Table S3 with their 
excretion rates.  
 
4.1.4. Chiral pharmaceuticals  
 More than 50% of pharmaceuticals currently used are chiral although they are usually manufactured 
as racemic mixtures (Petrie et al., 2015; Vazquez-Roig et al., 2014). Human metabolism and 
microbial processes during wastewater treatment can result in the enrichment of one specific 
enantiomer. Thus, the analysis of chiral compounds in wastewater allows to distinguish between 
usage of pharmaceuticals due to intentional human ingestion and from accidental release (direct 
disposal). For instance, enantioselective analysis was used by (Vazquez-Roig et al., 2014) to 
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tentatively propose direct disposal of atenolol where a moderate higher average daily load was 
observed. Recently, (Petrie et al., 2016) identified direct disposal of the antidepressant fluoxetine 
via the sewer network using wastewater analysis. 
 
4.2.  Endogenous compounds  
Endogenous chemicals are produced by biological processes associated with stress or 
normal metabolism. Changes in biological mechanisms may result in alterations of the endogenous 
compound production and, therefore, measurement of such compounds can be used as indicator of 
health status and disease (Daughton, 2012b; Group, 2001; Hagger et al., 2006). Endogenous 
biomarker analysis has been extensively studied as diagnostic or prognostic tools in clinical 
medicine, and can be further applied to the field of WBE (Daughton, 2012b). Thus far, the 
investigation of endogenous biomarkers has been more focused on diseases such as cancer, diabetes 
and cardiovascular disorder than on the overall health status. However, the number of biomarkers 
validated for routine clinical practice is rather limited (Poste, 2011; Rifai et al., 2006), which falls 
into even smaller numbers of biomarkers for WBE when considering only those excreted into urine. 
Nevertheless, a range of endogenous compounds have been suggested as wastewater biomarkers of 
effect including cancer (prostate specific antigen, α-fetoprotein) (Thomas and Reid, 2011; Yang et 
al., 2015c), oxidative stress (isoprostanes) (Daughton, 2012b; Ryu et al., 2015; Thomas and Reid, 
2011) and health (anti-inflammatory eicosanoids) (Daughton, 2012b). To date, studies conducted on 
candidate endogenous biomarkers in wastewater are based on targeted analysis of specific markers 
such as isoprostanes (Ryu et al., 2015) and cancer biomarkers (Yang et al., 2015c). However, it is 
important to note that omics approaches also hold promising and important roles in future 
developments and applications of endogenous biomarkers analysis in WBE (Rice et al., 2015). The 
added value of analyzing these compounds would reside mainly in relative comparisons, both intra- 
and inter- communities (Daughton, 2012b). Compared to the interpretation of the exogenous 
biomarkers, where absolute values are emphasized, the use of endogenous biomarkers is more 
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focused on detecting changes over time or between communities. Such data can reveal emerging 
trends (i.e., early warning system) and health disparities caused by various factors (e.g., exposure, 
lifestyle). 
 
4.3. DNA  
The demand for sensitive, low-cost and high-throughput methods to characterize 
DNA/RNA sequences has driven the development of molecular biology techniques and 
bioinformatics, i.e., PCR-based approaches and next generation sequencing (NGS) (Ryoo et al., 
2013). Massive sequencing is nowadays possible, owing to the development of different NGS 
platform that allows an entire genome to be sequenced in less than one week. These technical 
advances led to a rapid increase in new applications, including DNA-based health biomarkers. 
During the last decade an increasing number of studies took advantage of these developments, 
and applied them to the field of WBE. Several examples highlight the potential of the approach. 
In the field of virological surveillance, wastewater screening has been used to identify the viral 
strains that are circulating in the community, supporting epidemiological studies of the related 
viral infections and working as an early warning tool (Hellmér et al., 2014; Kokkinos et al., 
2011; Mclellan et al., 2013; Zhou et al., 2014). Hellmér et al. 2014 investigated the presence of 
eight pathogenic viruses (norovirus, astrovirus, rotavirus, adenovirus, Aichi virus, parechovirus, 
hepatitis A virus [HAV], and hepatitis E virus) in wastewater from Sweden to explore whether 
their identification could be used as an early warning of outbreaks. Results show that two strains 
were involved in an ongoing outbreak in Scandinavia and were also identified in samples from 
patients with acute hepatitis A in Gothenburg during spring of 2013.  
A similar framework has been applied in other areas such as the study of the 
epidemiology of the emerging human pathogens (Mclellan et al., 2013; Webb et al., 2015), and 
antibiotic resistance patterns of populations (Colomer-Lluch et al., 2014; Kumaraswamy et al., 
2014; McLellan and Eren, 2014). One of the most recent applications has been in the field of 
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human metabolic disorders. With the obesity epidemic reaching alarming levels, there is a need 
to set biomarkers to identify populations or sub-populations at risk (Lyssimachou et al., 2015). 
Recently, a good correlation has been established between the gut microbiome and obesity. In 
fact, only a few bacterial species are sufficient to distinguish between lean and obese individuals 
(Le Chatelier et al., 2013). These findings prompted a large study in the US using oligotyping of 
high-throughput 16S rRNA gene sequence data to screen wastewater from 71 cities. It was 
demonstrated that cities could be differentiated by their sewage bacterial communities, and the 
community structures were good predictors of a city’s estimated level of obesity (Newton et al., 
2015). This example illustrates that once specific biomarkers are identified, DNA-based analysis 
in wastewater can work as a powerful tool to support epidemiological studies 
 
5. POPULATION BIOMARKERS  
Accurate estimation of population size is necessary to normalize WBE data to the per 
capita level, which allows for temporal and spatial comparisons to be made (van Nuijs et al., 
2011b). A review of all uncertainties associated with WBE found that there is a direct 
relationship between the uncertainty in measuring the population size and the uncertainty in the 
calculated daily loads of drugs (Castiglioni et al., 2013; Lai et al., 2015a). Therefore, accurate 
data on population size are needed to make decisions involved with planning and forecasting, 
assessing services and infrastructure, policy making, informing legislation and resource 
allocation at the level of neighborhood, city, province or country.  
Current methodologies to estimate population size are based on public surveys (such as 
census taking), complemented with a wide array of demographic statistics, such as tourism and 
potential commuters. Census, however, can become increasingly outdated and cannot be easily 
updated to accommodate change such as births, deaths, and migration (movement). Ideally, the 
census should be able to estimate both the de jure and the de facto population. The de jure 
population comprises all “usual” residents, mainly those with formal residences. The de facto 
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population comprises all those who are present, regardless of the location of their formal or usual 
residence (Daughton, 2012a). A de facto population therefore includes all non-residents (e.g., 
commuters, visitors, tourists) and excludes all permanent residents who are absent. However, the 
census approach acquires a static snapshot estimate and usually succeeds in only capturing a 
portion of the population. Population size can also be estimated from hydrochemical parameters 
that are routinely determined in the WWTPs, including chemical oxygen demand (COD), 
biological oxygen demand (BOD) and total nitrogen and phosphorus. However, these parameters 
are highly influenced by wastewater composition (i.e. industrial, domestic or mixed).  
Addressing the population uncertainty and identifying suitable markers for the population 
size markers is thus an important aspect of WBE (Been et al., 2014; Brewer et al., 2012; Lai et 
al., 2011; O’Brien et al., 2014). Many compounds can be considered as biomarkers for 
population size. Possible candidates are both naturally occurring and synthetic xenobiotics (and 
their metabolites or formulation impurities), as well as products of endogenous metabolism. A 
variety of chemicals have been studied as biomarkers of population, including drugs (e.g., 
carbamazepine (Gasser et al., 2010)), biocides (e.g., triclosan (Singh et al., 2010)), chemicals in 
household cleaning agents, e.g., fluorescent whiteners, trialkylamines (Managaki et al., 2006; 
Valls et al., 1989), and food additives, e.g., sucralose (Oppenheimer et al., 2011). An essential 
characteristic for a biomarker to be useful for measuring population size is, in addition to the 
general requirements for a biomarker, to have a low variance in the per capita daily excretion 
(Daughton, 2012a); the knowledge of quantities excreted daily ensures that diurnal variations 
(e.g., resulting from circadian biorhythms) are fully accommodated. Another requisite for these 
groups of biomarkers is that daily per capita excretion should not be affected by variables such 
as season, weather and geographic location.   
 To date, none of the population size markers proposed have yet met all necessary criteria 
mentioned above and additional characteristics described before for a WBE biomarker should 
also be considered. Some specific applications are listed below. 
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5.1 Artificial sweeteners 
The most popular artificial sweeteners used in foodstuffs include acesulfame (ACE), 
alitame (ALI), aspartame (ASP), cyclamate (CYC), neotame (NEO), neohesperidin 
dihydrochalcone (NHDC), saccharin (SAC) and sucralose (SUC) (Table S4) (Kokotou et al., 
2012; Lange et al., 2012). All of them, except NEO and ALI, are allowed to be used as additives 
in food by the European Union (EPCD, 2003), whereas five of them, ACE, ASP, NEO, SAC and 
SUC are approved to be used in the United States (USFDA, 2006).  
After ingestion, ACE, CYC and SAC are unaffected by the human metabolism, and thus 
largely eliminated from human bodies mainly unchanged in urine (Fermin and Vallvey, 2004; 
Lange et al., 2012; Renwick, 1985; Roberts et al., 2000; Sardesai and Waldshan, 1991). Studies 
have shown that, due to variations in individual metabolism, CYC could be metabolized to 
cyclohexylamine and excreted in urine (Renwick et al., 2004). For ALI, 7–22% is excreted 
unchanged in feces, while the rest, about 78–93% is hydrolyzed to aspartic acid and alanine 
amide (Fermin and Vallvey, 2004). The glucuronide conjugates of ALI metabolites are the major 
urinary metabolites in the first 24 hours. ASP is largely broken down in human gut to aspartic 
acid, phenylalanine and methanol (Fermin and Vallvey, 2004; Lange et al., 2012). NEO and its 
metabolites are excreted in urine and feces (WHO Food Additive Series No. 52, 2004). Less than 
2% is excreted unchanged, but it is extensively metabolized in humans via de-esterification to N-
[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine (WHO Food Additive Series No. 52, 
2004). Minor metabolites of NEO include N-(3,3-dimethylbutyl)-L-aspartic acid, 3,3-
dimethylbutanoic acid and the carnitine conjugate and glucuronide conjugate of 3,3-
dimethylbutanoic acid (WHO Food Additive Series No. 52, 2004). NHDC is hydrolyzed in 
humans to isoferulic acid, 3-hydroxyphenylpropionic acid, and 3-hydroxycinnamic acid (Fermin 
and Vallvey, 2004; Lange et al., 2012). SUC is mainly excreted unchanged in human feces, 
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while 8-22% was excreted in urine unchanged together with its glucuronide conjugates (Roberts 
et al., 2000). 
ACE, CYC, SAC, and SUC were found highly stable in raw wastewater at 4oC and room 
temperature over four days (Ordóñez et al., 2012). Under these conditions, only 20-30% of ASP 
remained after one day and none left after two days. Similarly, the amount of NHDC was found 
less than 10% in the raw wastewater at 4oC after one day and linearly decreased at room 
temperature over three days. Similar results were also reported in another study, in which ACE, 
CYC, SAC and SUC remained stable in raw wastewater at 4oC over three weeks, whereas ASP 
and NHDC were degraded within a day (Tran et al., 2013). 
Since they are exclusively non-metabolized in humans and highly stable in wastewater, 
the parent compounds ACE, CYC, SAC and SUC can be measured for the WBE approach. 
However, the analysis of the metabolites of ALI, ASP, NEO and NHDC, rather than of the 
parent compounds, is required, since these artificial sweeteners are largely metabolized in 
humans. Stability tests for the metabolites in raw wastewater are also necessary for future 
studies. The use of artificial sweeteners has been shown to be highly related to human activities 
(Buerge et al., 2009) and, therefore, human consumption is considered as the major source of 
these substances in raw wastewater; however, other sources, such as animal feedings, agriculture 
farms and industries, can contribute to their presence in sewage systems (Kokotou et al., 2012).  
Certain artificial sweeteners also showed a specific weekly pattern: in general higher 
loads in influents (i.e. consumption) were observed during weekdays than during weekends 
(Kokotou et al., 2013). This could be associated with more commuters during the weekday than 
the weekend in the studied catchment. These previous studies together suggested that measuring 
artificial sweeteners could be useful for the WBE approach to understand the population flow in 
a given catchment. This concept of using human consumed chemicals, such as the artificial 
sweetener ACE, to back-estimate the population size from a given wastewater sample was firstly 
attempted and discussed by (Lai et al., 2011) and further refined using wastewater samples 
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collected on the census day and applying a Bayesian model (O’Brien et al., 2014). Importantly, 
with chemical-derived population estimates, the robustness of the WBE data was improved, 
since the total methodological uncertainty of the approach was reduced (Lai et al., 2015a, 2011). 
 
5.2. Nicotine 
Currently, nicotine and its metabolites have been used as population markers on two 
occasions (Chen et al., 2014; Senta et al., 2015a). In the first case, the authors focused solely on 
cotinine, whose loads varied only limitedly over one week and showed good correlation with the 
size of the investigated populations (i.e., correlation coefficient = 0.981) (Chen et al., 2014). 
However, geographical/cultural differences in tobacco use or fluctuations in the number of users 
have been raised as potential flaws to the use of cotinine as population marker (Chen et al., 
2014). Moreover, consumption of tobacco could change due to tax and other tobacco-related 
policies, which could affect the potential of nicotine and its metabolites as population markers.  
In the second study (Senta et al., 2015a), cotinine and trans-3’-hydroxycotinine loads were used 
to estimate the number of individuals contributing to the collected wastewater samples. Good 
agreement was found between nicotine metabolite load population estimates and census data, 
suggesting that the method is a viable approach to estimate the size of a population.  
 
5.3. Caffeine 
Caffeine and some of its major metabolites were recently tested as a population 
biomarkers. Caffeine was one of the compounds included in the exploratory study to estimate 
population size using samples collected on the census day and applying a Bayesian model 
(O’Brien et al., 2014). A strong correlation between caffeine mass loads and population size was 
observed. In the second study, generally good agreement between caffeine loads and 
hydrochemical parameters routinely determined at the WWTPs was found (Rico et al., 2016). In 
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another recent study, three major caffeine metabolites: 1-methylxanthine, 7-methylxanthine and 
paraxanthine were tested together with caffeine as possible population biomarkers (Senta et al., 
2015a). These compounds fulfilled some of the major requirements for an ideal biomarker - they 
are easily detectable and stable in wastewater samples. However, their mass loads in wastewater 
did not completely reflect the human excretion profile of caffeine, probably due to biases in 
caffeine pharmacokinetic data (see section 2.4 and Table S2) and additional sources of some 
metabolites and unconsumed caffeine. This makes the possibility of using caffeine and/or its 
metabolites as biomarkers for population size assessment rather difficult, at least without 
additional studies. 
 
5.4. Pharmaceuticals 
Concentrations and mass loads of pharmaceuticals in wastewater were used in the WBE field 
for the estimation of population size only on three occasions (Lai et al., 2011; O’Brien et al., 
2014; Rico et al., 2016). The investigated compounds by Lai et al. (Lai et al., 2011) were 
atenolol (beta-blocker), gabapentin (anti-convulsant), hydrochlorothiazide (diuretic), and 
venlafaxine (anti-depressant). Atenolol was concluded to be the best option for this aim for the 
specific catchment. In addition to the compounds selected by Lai et al., the same group also 
investigated carbamazepine (antiepileptic), codeine, ibuprofen, paracetamol (analgesics), 
furosemide (diuretic), iopromide (contrast medium), naproxen (anti-inflammatory) and salicylic 
acid (metabolite of acetylsalicylic acid) and the measured loads were used in a collective model 
for the estimation of the population size (O’Brien et al., 2014). By cross validating the data, the 
authors demonstrated that large populations sizes could be estimated fairly accurately using the 
information of multiple chemical mass loads. However, it could not be improved for small 
populations. In the work published by (Rico et al., 2016) twelve human urine biomarkers were 
tested to estimate population size, six of them being pharmaceuticals (hydrochlorothiazide, 
carbamazepine, codeine, naproxen, salicylic acid and atenolol). However, by using these 
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compounds, the population was under or overestimated compared to the hydrochemical 
population, but they have good prospects if the appropriate data sales are available.  
 
5.5. Endogenous compounds 
An alternative for estimating the population size in the catchment area of a WWTP relies 
on monitoring influent wastewater for a biomarker linked to human metabolism. Chemicals 
involved in endogenous metabolism avoid many of the problems encountered with xenobiotics, 
since their association with human activities has a higher fidelity. Yet, their main problem is 
excessive intra- and inter-individual variation in excretion. Biomarkers of endogenous origin 
derive from human biochemical processes and undergo continuous urinary or fecal excretion. 
Several endogenous biomarkers, which have been considered in the past or which have the 
potential to estimate the population size more accurately (Table S4), are further discussed.   
An important endogenous biomarker, widely used in clinical chemistry and with detailed 
knowledge about its excretion, is creatinine (CR). A small portion of creatine (and 
phosphocreatine), which is stored predominately in skeletal muscle, is continually converted to 
form the endogenous anhydride, CR (a nitrogenous waste product cleared via the kidney); the 
rate of conversion, in males for example, is about 1.6–1.7% per day. The major factors involved 
with variability in CR output have been summarized by (Ryan et al., 2011). However, intra- and 
inter-day CR excretion is not constant and daily excreted quantities can have high variance, 
being strongly influenced by diet composition. In addition, CR is being increasingly used as a 
food and nutritional supplement, adding yet another source of potential variation to CR excretion 
rates. Although CR has been used in WBE studies as population marker (Brewer et al., 2012; 
Chiaia et al., 2008), it was shown to be unstable in wastewater (completely decomposed within 
24 h) (Chen et al., 2014).  
Another potential biomarker is coprostanol (CoP) that originates from gut microbial 
metabolism, making up roughly 60% of the overall sterol content in human feces. CoP is poorly 
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absorbed from the gut (it does not undergo enterohepatic circulation) and is therefore fully 
excreted in the feces. Since the 2000s, CoP has been used as anthropogenic marker in wastewater 
and to gauge the degree of dilution of raw or treated wastewater in receiving surface water 
(Takada and Eganhouse, 1998). However, CoP is excreted by various vertebrates in differing 
absolute and relative quantities and it is sometimes difficult to distinguish between human and 
animal contamination (Bull et al., 2002). Furthermore, CoP adsorbs substantially onto particulate 
matter found in wastewater and was thus discarded as potential population marker (Chen et al., 
2014). Similar results were obtained for cholesterol (Chen et al., 2014); cortisol and 
androstenedione were investigated, but rapidly degraded in wastewater (Chen et al., 2014).  
Another example of biomarker relatively unique to human metabolism is 1-aminopropan-
2-one (1-aminopropanone: APR; 1-aminoketone). Through 1-aminopropan-2-ol, APR serves as a 
precursor to vitamin B-12 (Fitzsimons and Belt, 2005). It is very water soluble and it is excreted 
via urine, but in much lower daily quantities than CoP. However, it is sometimes found in 
wastewater at levels higher than in urine, implicating potential de novo microbial formation in 
sewage (Fitzsimons and Belt, 2005), whilst it could not be detected on other occasions (Singh 
and Gardinali, 2006). 
5-hydroxyindoleacetic acid (5-HIAA), a metabolite of serotonin, has also been 
investigated. Its excretion might be altered due to diseases (e.g., carcinoid tumors (Zuetenhorst, 
2004)) and diet (i.e., some fruits and nuts (Feldman and Lee, 1985) and salt intake (Sharma et al., 
1993). Furthermore, intra- and inter-individual variability in excretion has also been highlighted 
(Curtin et al., 1996). Results from wastewater analysis showed good correlation with census data 
and the authors considered it as a promising marker (Chen et al., 2014).  
Ammonium (NH4+) represents the major form in which ammonia (NH3) is found in 
wastewater and originates from the breakdown of urea (Udert et al., 2006). It is mainly 
introduced via toilets (Butler et al., 1995) and it is routinely measured by WWTP as a water 
quality parameter. It is supposedly less affected by non-human sources compared to conventional 
42 
 
parameters (e.g., chemical or biological oxygen demand, total phosphorous) (van Nuijs et al., 
2011b) and can potentially be measured online using ion-selective electrodes. Fluctuations in 
ammonium loads have been shown to link well to population dynamics (Been et al., 2014). Yet, 
its use to estimate absolute figures of the size of the de facto population might be undermined in 
rural areas due to the contribution of agricultural sources.  
 
5.6. DNA 
Deoxyribonucleic acid (DNA) is a nucleic acid that carries most of the genetic 
instructions from all known living organisms and many viruses. DNA can be naturally shed into 
the environment through urine, feces, exudates or tissue residues. Compared to most of chemical 
compounds as a candidate of population biomarkers, DNA is much more stable and able to 
persist in the environment from month to hundred years depending on species (Prüfer et al., 
2014; Thomsen and Willerslev, 2015). DNA biomarkers have been widely used in the field of 
medical diagnostics and biomedicine (Altintas and Tothill, 2013; Liu et al., 2011; Ralla et al., 
2014; Wang et al., 2012). For WBE, DNA has a great potential to act as a population biomarker, 
not only because of its little affinity to other species in wastewater and constant excretion by 
humans, but also for its extreme stability and the possibility of being quantifiable Those robotic 
characteristics well meet the proposed criteria of a proper population biomarker candidate 
(Dejean et al., 2011; Thomsen and Willerslev, 2015). 
Typically, the changes of DNA component and structure such as DNA damage, repair 
and mutation could be used as biomarkers. Recently, a H2AX histone phosphorylation assay was 
developed as DNA damage biomarker for human population study, as it represents an early event 
in the cellular response against DNA double-strand breaks (Sánchez-Flores et al., 2015). 
However, to select a population biomarker for WBE uses, one of the crucial criteria is to screen 
human specific DNA. Wastewater is a complex matrix, which may contain DNA from various 
species such as plants, animals, and viruses. A recent study by Yang et al (Yang et al., 2015a, 
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2015b) has proposed to use community sewage sensors to identify human-specific mitochondrial 
DNA as a potential population biomarkers. In this study, human specific mitochondrial DNA 
associated with disease biomarkers (Liu et al., 2011; Tipirisetti et al., 2014) was amplified from 
wastewater by a specifically designed primer using quantitative real-time polymerase chain 
reaction (PCR) (Yang et al., 2015a). More importantly, the amplicons were detectable by an 
electrochemical biosensor based on a custom synthesized ferrocence intercalator as a signal 
transducer. The developed biosensors allow for the detection of single nucleotide variation and 
enable the potential of portable sensors for rapid identification of specific human biomarkers in 
wastewater.  
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6. CONCLUSIONS AND FUTURE PERSPECTIVES 
WBE is a rapidly developing scientific discipline with a strong transdisciplinary 
character. It has shown great progress, and opens up many possibilities for expanding its 
application to provide relevant information about lifestyle and public health.  
This review has outlined potential wastewater biomarkers of exposure or effect that could 
be used for future applications associated with lifestyle and wellbeing studies. However, it has 
also discussed limitations and highlighted that more research is needed, for various proposed 
biomarkers, before WBE can appropriately be applied. Moreover, several trends, needs and 
recommendations are indicated: 
- Human pharmacokinetic data (metabolism and urinary profile of excretion) are necessary to 
ensure that the candidate biomarker is formed in the body in a high proportion and is excreted 
mainly via urine. This information is highly relevant not only to back-calculate the 
consumption/exposure of a certain substance by a community, but also to distinguish the 
amount of a substance coming from human or other sources.  
- In-sample and in-sewer stability studies are needed for a better application in WBE. Stability 
tests are often performed in the laboratory, trying to reproduce the real conditions of 
temperature and sewage composition or in-sewer conditions. An alternative would be the use of 
in-silico tools to predict the stability of a compound in wastewater treatment processes. These 
models do not guarantee the formation of a biotransformation product, so it may be used as an 
indicator or a guide about the in-sewer stability of a residue and its potential adsorption (Reid 
2014). Sorption onto the solid particulate or the conjugation of the biomarkers must also be 
taken into account when assessing stability.   
- Source identification is needed to ensure that discharges from exogenous sources that might 
cause overestimation of the real amounts consumed are considered.  
- Cross validation of data (e.g. concentrations of pharmaceuticals in wastewater with bench-top 
sales) is recommended for all applications. 
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- Multiple biomarkers for estimating the population size need to be set to allow for the 
normalization of the data. The development of portable biosensors may allow rapid estimation 
of the population contributing to the wastewater samples in the near future. 
- Regular monitoring of sewage for viruses based on similar DNA biosensors may give an early 
warning of a possible upcoming outbreak.  
- Omics approaches also hold promising and important roles in future developments and 
applications of endogenous biomarkers analysis in WBE. 
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Table 1. Overview of the most relevant biomarkers used so far and potential biomarkers (for more 
details, please read the corresponding text and/or supporting information). 
 
Class Parent compound Biomarker/potential biomarker 
WBE 
applicatio
n 
Reference 
Illicit drugs 
Cocaine Benzoylecgonine YES 
(Castiglioni and 
Gracia-Lor, 
2015; Gracia-
Lor et al., 
2016) 
Amphetamine Amphetamine YES 
(Castiglioni and 
Gracia-Lor, 
2015; Gracia-
Lor et al., 
2016) 
Methamphetamine Methamphetamine YES 
(Castiglioni and 
Gracia-Lor, 
2015; Gracia-
Lor et al., 
2016) 
MDMA MDMA YES 
(Castiglioni and 
Gracia-Lor, 
2015; Gracia-
Lor et al., 
2016) 
THC/Cannabis THC-COOH YES 
(Castiglioni and 
Gracia-Lor, 
2015; Gracia-
Lor et al., 
2016) 
Alcohol Ethanol Ethyl sulfate YES 
(Rodríguez-
Álvarez et 
al., 2015) 
Tobacco Nicotine Cotinine + trans-3'-hydroxycotinine YES 
(Castiglioni et 
al., 2015b) 
Caffeine Caffeine See Table S1 NO  
NPS  See Table S1 NO  
Pesticides 20 pyrethroids  3-PBA YES (Rousis et al., 2016b) 
Permetrin, 
cypermetrin, 
cyflutrin cis-DCCA YES 
(Rousis et al., 
2016b) 
Permetrin, 
cypermetrin, 
cyflutrin trans-DCCA YES 
(Rousis et al., 
2016b) 
Mycotoxines  See Table S2 NO  
Parabens  See Table S2 NO  
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UV-filters  See Table S2 NO  
Plasticizers  See Table S2 NO  
Flame 
retardants  See Table S2 NO  
Pharmaceuticals 
Atenolol Atenolol YES 
(Baz-Lomba et 
al., 2016; van 
Nuijs et al., 
2015) 
Citalopram Citalopram YES 
(Baz-Lomba et 
al., 2016; van 
Nuijs et al., 
2015) 
Carbamazepine Carbamazepine YES 
(Baz-Lomba et 
al., 2016; van 
Nuijs et al., 
2015) 
Diclofenac Diclofenac YES (Baz-Lomba et al., 2016) 
Metformin Metformin YES (van Nuijs et al., 2015) 
Valsartan Valsartan YES (van Nuijs et al., 2015) 
Benzodiazepines Oxazepam Oxazepam YES (Baz-Lomba et al., 2016) 
Artificial 
sweeteners Acesulfame Acesulfame YES 
(Lai et al., 
2015a) 
Endogenous 
Compounds 
Serotonin 5-HIAA YES (Rico et al., 2016) 
Ammonia Ammonium YES (Been et al., 2014) 
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